Discover
UTHR
United Therapeutics Corporation
525.04
1 x 525.34
1 x 525.83
bid
ask
-
4.62
0.87%
01:34 PM
timesize
| Ytd | 7.76% | |
| 1y | 74.76% |
523.65
day range
533.06
292.34
52 week range
609.35
| Open | 528.06 | Prev Close | 529.66 | Low | 523.65 | High | 533.06 | Mkt Cap | 22.28B |
| Vol | 109.83K | Avg Vol | 509.20K | EPS | 27.95 | P/E | 18.78 | Forward P/E | 17.87 |
| Beta | 0.59 | Short Ratio | 3.81 | Inst. Own | 100.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 539.30 | 200-d Avg | 517.24 | 1yr Est | 656.15 |
| Income Statement | |||
| Total Revenue | 783.30M | ||
| Revenues (USD) | 783.30M | ||
| Cost of Revenue | 99.50M | ||
| Gross Profit | 683.80M | ||
| Operating Expenses | 353.00M | ||
| Research and Development Expense | 146.30M | ||
| Selling, General and Administrative Expense | 206.70M | ||
| Operating Income | 330.80M | ||
| Interest Expense | 2.90M | ||
| Income Tax Expense | 39.70M | ||
| Net Income | 333.00M | ||
| Net Income Common Stock | 333.00M | ||
| Net Income Common Stock (USD) | 333.00M | ||
| Consolidated Income | 333.00M | ||
| Earnings per Basic Share | 7.82 | ||
| Earnings per Basic Share (USD) | 7.82 | ||
| Earnings per Diluted Share | 7.27 | ||
| Earning Before Interest & Taxes (EBIT) | 375.60M | ||
| Earning Before Interest & Taxes (USD) | 375.60M | ||
| Weighted Average Shares | 42.60M | ||
| Weighted Average Shares Diluted | 45.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.80B | ||
| Cash and Equivalents (USD) | 1.80B | ||
| Investments | 2.00B | ||
| Investments Current | 859.10M | ||
| Investments Non-Current | 1.14B | ||
| Trade and Non-Trade Receivables | 310.30M | ||
| Current Assets | 3.48B | ||
| Property, Plant & Equipment Net | 1.93B | ||
| Total Assets | 7.22B | ||
| Current Liabilities | 607.80M | ||
| Total Liabilities | 819.80M | ||
| Accumulated Retained Earnings (Deficit) | 9.16B | ||
| Accumulated Other Comprehensive Income | -16.20M | ||
| Shareholders Equity | 6.40B | ||
| Shareholders Equity (USD) | 6.40B | ||
| Assets Non-Current | 3.74B | ||
| Goodwill and Intangible Assets | 114.10M | ||
| Inventory | 193.80M | ||
| Liabilities Non-Current | 212.00M | ||
| Trade and Non-Trade Payables | 497.80M | ||
| Tax Assets | 311.60M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 24.20M | ||
| Net Cash Flow from Financing | 122.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 523.50M | ||
| Capital Expenditure | -108.00M | ||
| Issuance (Purchase) of Equity Shares | 126.30M | ||
| Issuance (Repayment) of Debt Securities | -3.40M | ||
| Net Cash Flow from Investing | 87.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 195.50M | ||
| Net Cash Flow from Operations | 313.60M | ||
| Share Based Compensation | 43.40M | ||